
|Articles|February 15, 2004
FDA multicenter trial confirms CK safety, efficacy for hyperopia
Anaheim, CA-Conductive keratoplasty (CK), a thermokeratoplasty technique used to reshape the cornea, appears to be a safe and effective approach for treating low to moderate hyperopia with little or no induced astigmatism, according to Marguerite B. McDonald, MD, medical monitor of the FDA multicenter trial.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Metformin use associated with reduced incidence of intermediate AMD
2
MeiraGTx Licenses complement-targeted geographic atrophy program from ZipBio
3
Last year in glaucoma at EnVision Summit 2025
4
Looking back at the 2025 EnVision Summit
5




























